Liver fibrosis progression is faster in HIV/HCV coinfected than in HCV mono-infected patients. We aimed at assessing the rate of progression to advanced liver fibrosis among HIV-infected patients on suppressive ART, with or without HCV co-infection, and identifying its predictors.
Progression of liver fibrosis among HIV-infected patients under suppressive antiretroviral therapy: role of untreated HCV and other unrelated factors in the ICONA Foundation Study Cohort.
G. NunnariMembro del Collaboration Group
;G. F. Pellicanò.Membro del Collaboration Group
2016-01-01
Abstract
Liver fibrosis progression is faster in HIV/HCV coinfected than in HCV mono-infected patients. We aimed at assessing the rate of progression to advanced liver fibrosis among HIV-infected patients on suppressive ART, with or without HCV co-infection, and identifying its predictors.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
